Evidence map›Paper›PMID 31459697›Full record

ArticleACS omega2019

Influence of DFT Functionals and Solvation Models on the Prediction of Far-Infrared Spectra of Pt-Based Anticancer Drugs: Why Do Different Complexes Require Different Levels of Theory?

Eunice S H Gwee, Zoe L Seeger, Dominique R T Appadoo, Bayden R Wood, Ekaterina I Izgorodina

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Eunice S H GweeMonash Computational Chemistry Group, School of Chemistry and Centre for Biospectroscopy, School of Chemistry, Monash University, 17 Rainforest Walk, Clayton, Victoria 3800, Australia.
Zoe L SeegerMonash Computational Chemistry Group, School of Chemistry and Centre for Biospectroscopy, School of Chemistry, Monash University, 17 Rainforest Walk, Clayton, Victoria 3800, Australia.
Dominique R T AppadooAustralian Synchrotron, 800 Blackburn Road, Clayton, Victoria 3168, Australia.
Bayden R WoodMonash Computational Chemistry Group, School of Chemistry and Centre for Biospectroscopy, School of Chemistry, Monash University, 17 Rainforest Walk, Clayton, Victoria 3800, Australia.
Ekaterina I IzgorodinaMonash Computational Chemistry Group, School of Chemistry and Centre for Biospectroscopy, School of Chemistry, Monash University, 17 Rainforest Walk, Clayton, Victoria 3800, Australia.
Monash University · AUAustralian Synchrotron · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computational modeling was applied to far-infrared (FIR) spectra of Pt-based anticancer drugs to study the hydrolysis of these important molecules. Here, we present a study that investigates the influence of different factors-basis sets on non-Pt atoms, relativistic effective core potentials (RECPs) on the Pt atom, density functional theory (DFT) functionals, and solvation models-on the prediction of FIR spectra of two Pt-based anticancer drugs, cisplatin and carboplatin. Geometry optimizations and frequency calculations were performed with a range of functionals (PBE, PBE0, M06-L, and M06-2X), Dunning's correlation-consisted basis sets (VDZ, VTZ, aVDZ, and aVTZ), RECPs (VDZ-pp, VTZ-pp, aVDZ-pp, and aVTZ-pp), and solvation models (IEFPCM, CPCM, and SMD). The best combination of the basis set/DFT functional/solvation model was identified for each anticancer drug by comparing with experimentally available FIR spectra. Different combinations were established for cisplatin and carboplatin, which was rationalized by means of the partial atomic charge scheme, ChelpG, that was utilized to study the charge transfer between the Pt ion and ligands in both cisplatin and carboplatin.

Identifiers

PMID31459697
PMCPMC6649127
OpenAlexW2921341263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.